Steve Gillis - Profile and Investment Details

Investor Profile

Steve Gillis is a Venture Capital, Private Equity Firm, Investor based in Seattle, Washington, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics, Cero Therapeutics, Encoded Therapeutics, Locanabio, Faraday Pharmaceuticals, AgBiome, Metacrine, One BioMed, Theraclone Sciences, Hangzhou Just Biotherapeutics (Just China), Biopalette, Karuna Therapeutics, Homology Medicines, Sana BiotechnologyNebula Genomics, Nohla Therapeutics, Hua Medicine, Vividion Therapeutics, ImmuneID, Epirium Bio, Singleron Biotechnologies, Ultivue, Verve Therapeutics, Geneception, Aspen Neuroscience, Bit Bio, Erasca, Codiak Biosciences, Semma Therapeutics, UNITY Biotechnology, AnchorDx, Encodia, Sesh, EGenesis, Transcenta, Omniome, Maze Therapeutics, Resilience, ROME Therapeutics, Walden Biosciences, Sonoma BioTherapeutics, Vir Biotechnology, BlackThorn Therapeutics, Glympse Bio, Scholar Rock, Dewpoint Therapeutics, Volastra Therapeutics, Agrivida, ImmusanT, EQRx, Vizgen, Magnolia NeuroSciences, VentiRx Pharmaceuticals, HiberCell, Carrick Therapeutics, Gossamer Bio, Insitro, LunaPBC, Autobahn Therapeutics, CStone Pharmaceuticals, Nutcracker Therapeutics, Mindstrong, Boundless Bio, LunaDNA, Brii Biosciences, Beam Therapeutics, Voxel8, Cytrellis Biosystems, Qihan Biotech, . Over time, Steve Gillis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Steve Gillis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Data Science, High-growth Startups, Wellness, Enterprise Software, Fundraising, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Portfolio Management, Startups, Information Technology (IT), Software, Biotechnology, Medical Devices, Drug Development, Networking, Genomics, Precision Medicine, Disruptive technology, Consumer Software, Gene Therapy, Consulting, Hardware, Personalized Medicine, Health Diagnostics, Market Intelligence, Digital Health, Professional Networking, Medical, Information Technology, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Steve Gillis, as their portfolio suggests a familiarity and interest in this area.

Understanding Steve Gillis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.